World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 October 2017
Main ID:  NCT00716482
Date of registration: 14/07/2008
Prospective Registration: No
Primary sponsor: SuperSonic Imagine
Public title: Ultrasound Elastography of Breast Lesions BE1
Scientific title: Assessment of the Clinical Value of SuperSonic Shear Wave Elastography in the Ultrasonic Evaluation of Breast Lesions
Date of first enrolment: July 2008
Target sample size: 1681
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT00716482
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
France Germany Italy United Kingdom United States
Contacts
Name:     David O Cosgrove, MD
Address: 
Telephone:
Email:
Affiliation:  Hammersmith Hospitals NHS Trust
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients who have been referred to a breast ultrasound because of a positive physical
palpation and/or positive mammograms and/or positive ultrasound and/or positive MRI.

- female

- age 21 or older

- provide informed consent

Exclusion Criteria:

- Women who are unwilling or unable to provide informed consent

- Women with breast implants

- Women with superficial lesions or lesions on skin (with the most superficial surface
of the lesion within 5 mm of the skin surface)

- Women who are pregnant or breastfeeding

- Women who are undergoing chemotherapy or radiotherapy for any cancer

- Women with previous breast conserving surgery on the breast of interest Note: Previous
excision of a benign lesion 4 cm or more away from the suspected lesion does not
constitute an exclusion criterion.



Age minimum: 21 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Breast Neoplasms
Intervention(s)
Primary Outcome(s)
Estimates of Effect of Selectively Upgrading BIRADS Category 3 and Downgrading BIRADS 4a Masses Based on SWE Features. Overall Specificity and Sensitivity of BI-RADS Score Using Conventional B-mode Ultrasound vs. B-mode + Certain SWE Characteristics [Time Frame: 2 years]
Secondary Outcome(s)
Interobserver Agreement of B Mode Ultrasound and SWE Features [Time Frame: performed on the same day, after study completion]
Intraobserver Reliability of Quantitative SWE Measurements [Time Frame: performed on the same day, within 2 years from study start date]
Qualitative Intraobserver Reproducibility of SWE Related to Homogeneity Feature [Time Frame: performed on the same day, within 2 years from study start date]
Secondary ID(s)
A00152-53
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 09/09/2013
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT00716482
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history